Literature DB >> 3050112

Opsonophagocytosis of Campylobacter pylori.

S S Das1, Q N Karim, C S Easmon.   

Abstract

The opsonic activity of human serum from various sources against Campylobacter pylori was compared. All sera, whether from control subjects with no symptoms of gastritis or peptic ulceration, or from symptomatic patients from whom C. pylori had or had not been isolated, opsonised C. pylori equally well. Opsonisation depended on the alternative pathway of complement activation but not on antibody. These findings suggest that antibody plays no role in protection against C. pylori and that the presence of antibody in patients' sera is mainly of diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050112     DOI: 10.1099/00222615-27-2-125

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis.

Authors:  S J Hessey; J Spencer; J I Wyatt; G Sobala; B J Rathbone; A T Axon; M F Dixon
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

2.  Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection.

Authors:  B A van de Wouw; W A de Boer; A R Jansz; R T Roymans; A P Staals
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.

Authors:  Q B Zhang; I M Nakashabendi; M S Mokhashi; J B Dawodu; C G Gemmell; R I Russell
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

4.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

5.  Neutrophil activation by Helicobacter pylori.

Authors:  C Mooney; J Keenan; D Munster; I Wilson; R Allardyce; P Bagshaw; B Chapman; V Chadwick
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

6.  Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease.

Authors:  H Rautelin; B Blomberg; H Fredlund; G Järnerot; D Danielsson
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

7.  Neutrophil activation by Campylobacter concisus.

Authors:  Nina B Sørensen; Hans L Nielsen; Kim Varming; Henrik Nielsen
Journal:  Gut Pathog       Date:  2013-07-03       Impact factor: 4.181

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.